Echelon Diagnostics, a provider of genomic healthcare AI imaging and big data solutions, announced a collaboration with Oncocyte Corporation, a molecular diagnostics company specializing in oncology.
The two companies will work together to develop analytical software that can scale to support the commercial expansion of Oncocyte’s tests and solutions that may help diagnosis and treatment of cancer, leading to improved patient outcomes and reducing the overall cost of care.
“EchelonDx was the right partner to help us build the software solution that allows us to scale and launch our proprietary tests worldwide in a manner that ensures the integrity of the information processing and built-in quality control to ensure uniform and accurate testing,” said Doug Ross, MD PhD, Chief Scientific Officer of Oncocyte.
Echelon Diagnostics provides clinical contract research and IVD medical device development with data solutions that integrate AI, image analysis, informatics, and liquid biopsy to improve the human condition.
